Non-clinical safety assessment of VK4-116 to support human patients afflicted with severe pain disorders.
Ended Awarded Last action
- Contract number
- 75N95019F00088
- Awardee
-
Battelle Memorial Institute UEI F125YU6SWK59
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,634,086
Award facts
- Opportunity
-
- CRO Support for NCATS In Vitro and In Vivo Toxicology Studies Pre-Solicitation · N01TR172002 · Posted Apr 7, 2020
- CRO Support for NCATS In Vitro and In Vivo Toxicology Studies Award Notice · Posted May 2, 2016
- Contract value 96% obligated
-
- $2,634,086.00 Current, with exercised options
- $2,743,201.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Columbus, OH 43201, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $149,494 | |
| Supplemental Agreement for work within scope | $615,090 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $1,869,502 |
About this award
This is a $2,743,201.00 Cost Plus Fixed Fee contract awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to Battelle Memorial Institute, a non-profit research and development organization, for non-clinical safety assessment of VK4-116 to support human patients with severe pain disorders. The contract is a delivery order under Battelle's CRO Support for NCATS In Vitro and In Vivo Toxicology Studies master IDIQ contract. Battelle has subcontracted portions of the work to Inotiv, Inc., a for-profit provider of preclinical drug discovery and development services, for rodent microscopic evaluation and IND-enabling toxicology studies. The contract does not have a set-aside designation.
Quick answers
Who was awarded contract 75N95019F00088?
75N95019F00088 was awarded to Battelle Memorial Institute by National Institute on Drug Abuse (National Institutes of Health) on August 7, 2019.
How much is contract 75N95019F00088 worth?
The government has obligated $2,634,086 on 75N95019F00088. Its potential value, with all options, is $2,743,201.
Which agency awarded contract 75N95019F00088?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95019F00088, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Is contract 75N95019F00088 an order under another contract?
Yes. 75N95019F00088 is a delivery order under HHSN271201700015I, an indefinite delivery contract, on CRO Support for NCATS In Vitro and In Vivo Toxicology Studies.
Was contract 75N95019F00088 competed?
The extent of competition for 75N95019F00088 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award